Drug
Pixantrone clinical trials
Includes 1 study of Pixantrone dimaleate.
- studies test it
- 12
- open now
- 0
- in phase 3
- 4
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 4
CTI BioPharma (8) · The Lymphoma Academic Research Organisation (1) · Johannes Gutenberg University Mainz (1) · Anne Beaven, MD (1) · Alliance for Clinical Trials in Oncology (1)
Often tested with
Tested in the same studies.
Rituximab (6) · Fludarabine (2) · Obinutuzumab (1) · Bendamustine (1) · Cyclophosphamide (1) · Vincristine (1) · Prednisone (1) · Dexamethasone (1)
Studies
Open first, then newest update. How each study uses pixantrone is read from its arms, and is right about nine times in ten.
Testing it · 12
- Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin LymphomaCompletedPhase 2The Lymphoma Academic Research OrganisationNCT03458260Written as Pixantrone
- Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic ImpairmentWithdrawnPhase 1CTI BioPharmaNCT01632436Written as Pixantrone
- Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)CompletedPhase 1/2CTI BioPharmaNCT00106600Written as Pixantrone IV infusion
- GOAL: GA101 Plus Pixantrone for Relapsed Aggressive LymphomaCompletedPhase 2Johannes Gutenberg University MainzNCT02499003Written as Obinutuzumab and Pixantrone
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell TransplantCompletedPhase 3CTI BioPharmaNCT01321541Written as Pixantrone + Rituximab
- Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHLWithdrawnPhase 3CTI BioPharmaNCT00577161Written as fludarabine, rituximab, pixantrone
- IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's LymphomaCompletedPhase 1Anne Beaven, MDNCT01491841Written as Bendamustine + Rituximab + Pixantrone
- BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedPhase 3CTI BioPharmaNCT00088530Written as pixantrone, cyclophosphamide, vincristine, rituximab, prednisone
- Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory CancerWithdrawnPhase 1CTI BioPharmaNCT02800889Written as Pixantrone
- Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedPhase 2Alliance for Clinical Trials in OncologyNCT01086605Written as pixantrone dimaleate
- Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCompletedPhase 1CTI BioPharmaNCT00060684Written as Pixantrone (BBR 2778)
- Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's LymphomaTerminatedPhase 3CTI BioPharmaNCT00060671Written as Pixantrone (BBR 2778)
Given in every arm · 1 — pixantrone is usual care beside what is tested
Codes
What other systems call pixantrone · ClinicalTrials.gg INT003780
- MeSH (NLM) C086548pixantroneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F5SXN2KNMRPIXANTRONEConfirmed FDA, NLM, Wikidata
- Wikidata Q7199690pixantroneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C26663PixantroneOne source FDA
- DrugBank DB06193One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C086548 | pixantrone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F5SXN2KNMR | PIXANTRONE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7199690 | pixantrone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C26663 | Pixantrone | One source FDA |
| DrugBank | DB06193 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.